Informing Alzheimer's Biomarker Communication: Concerns and Understanding of Cognitively Unimpaired Adults During Amyloid Results Disclosure
The Journal of Prevention of Alzheimer's Disease · 2024
DOI: 10.14283/jpad.2024.151 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Prevention of Alzheimer's Disease, 2024. Verfasst von F B Ketchum und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fred B. Ketchum, Department of Neurology, School of Medicine and Public Health, University of Wisconsin, Madison, 1685 Highland Avenue, Madison, WI 5…. Hauptthemen laut MEDLINE: Alzheimer Disease, Biomarkers, Positron-Emission Tomography. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
BACKGROUND: Biomarker results are increasingly disclosed in research and clinical settings, but less is known about how individuals interpret their results or concerns raised during the disclosure visit that may need to be addressed by clinicians to ensure appropriate disclosure. METHODS: Fifty-two cognitively unimpaired older adults aged 65 to 89 years old from the Wisconsin Registry for Alzheimer's Prevention, who had undergone an amyloid PET scan in the previous 18 months, were enrolled in the disclosure substudy. After ensuring psychological readiness, trained study clinicians disclosed amyloid PET results using a structured protocol. We assessed participants' level of understanding, concerns, and the perceived personal significance of their biomarker results during the disclosure visit through a series of question prompts in real-time. RESULTS: Thirty-four received a non-elevated amyloid result and 18 received an elevated result. The average age was 72.2 years (range 65-81); most were women (64%) and non-Hispanic White (92%). Participants understood their results (98%), and both non-elevated and elevated groups provided similar responses around topics of sharing with others, privacy, accuracy of testing, and risk. Participants with elevated results were significantly more likely than those with non-elevated results to want to change their lifestyle (78% vs 12%, p=
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fred B. Ketchum, Department of Neurology, School of Medicine and Public Health, University of Wisconsin, Madison, 1685 Highland Avenue, Madison, WI 53705, USA, Phone (608) 265-5523, Fax (608) 263-0412, fketchum@neurolog…
Förderung
- NIA NIH HHS
Zitieren
APA
Ketchum, F. B., Erickson, C. M., Basche, K. E., Chin, N. A., Eveler, M. L., Conway, C. E., Coughlin, D. M., & Clark, L. R. (2024). Informing Alzheimer's Biomarker Communication: Concerns and Understanding of Cognitively Unimpaired Adults During Amyloid Results Disclosure. The Journal of Prevention of Alzheimer's Disease. https://doi.org/10.14283/jpad.2024.151
Vancouver
Ketchum FB, Erickson CM, Basche KE, Chin NA, Eveler ML, Conway CE, et al. Informing Alzheimer's Biomarker Communication: Concerns and Understanding of Cognitively Unimpaired Adults During Amyloid Results Disclosure. The Journal of Prevention of Alzheimer's Disease. 2024. doi:10.14283/jpad.2024.151
BibTeX
@article{Ketchum2024,
author = {Ketchum, F B and Erickson, C M and Basche, K E and Chin, N A and Eveler, M L and Conway, C E and Coughlin, D M and Clark, L R},
title = {Informing Alzheimer's Biomarker Communication: Concerns and Understanding of Cognitively Unimpaired Adults During Amyloid Results Disclosure},
journal = {The Journal of Prevention of Alzheimer's Disease},
year = {2024},
doi = {10.14283/jpad.2024.151}
}
EUVIMED